|Approval Date||16 Oct 2002|
|Signature Date||16 May 2003|
|Planned Completion Date||31 Dec 2007|
|Last Disbursement Planned Date||30 Jun 2007|
|Sovereign / Non-Sovereign||Sovereign|
|DAC Sector Code||12110|
This project focuses on Phase II of the African Program for Onchocerciasis Control (APOC). The program will contribute to the reduction of onchocerciasis morbidity in endemic countries. It responds to the Bank's vision of poverty reduction and is consistent with the Bank's health and environmental policies. The success of Phase I prompted the international community to commit to continuing the fight against the disease in the 19 endemic African countries. Phase II of APOC will establish sustainable onchocerciasis control operations in African countries where the disease is still a major public health problem and an obstacle to socio-economic development. It comprises the following four components: (i) Ivermectin treatment under the Community Directive; (ii) Point elimination of the vector; (iii) Research and evaluation and (iv) Program Management. The total cost of this program, which will be implemented over a period of 9 years, is estimated at UA 85.00 million.
The sector goal of the program is the elimination of onchocerciasis as a major public health problem and an obstacle to socio-economic development in the 14 countries concerned, the improvement of the well-being of its inhabitants and the reduction of the poverty. The specific objective of the program is to establish an effective, autonomous and sustainable community-directed Ivermectin treatment system in all endemic areas of the program's geographical area and to eliminate the vector in restricted foci using pesticides that do not have an adverse effect on ecosystems.
Beneficiaries are communities that are underserved by national health services due to lack of resources. These communities are also the poorest in the APOC area. 70 million people will be affected by the program and will participate in the fight against the disease. The population eligible for treatment is estimated at 59 million, of which the program has set a target of 50 million in 2010.
African Development Fund
World Health Organization
|Last Update||30 Nov 2022|
|7 21||Central African Republic|
|-2.5 23.5||DR Congo|
|-1.0 15.5||Republic of the Congo|